SOURCE: Alpharma

February 22, 2008 11:12 ET

Alpharma Announces Information for Fourth Quarter 2007 Conference Call

BRIDGEWATER, NJ--(Marketwire - February 22, 2008) - Alpharma Inc. (NYSE: ALO) announced that the company will release its fourth quarter 2007 earnings before the market opens on Tuesday, February 26, 2008. Alpharma's management will conduct a conference call / webcast on Tuesday, February 26, 2008 beginning at 8:30 AM Eastern Standard Time to discuss its fourth quarter and full year results. The presentation which management will refer to on the call will be available on the company's website in the "Investor's Support" section at

The call will be open to all interested parties and may be accessed by using the following information:

                          CONFERENCE CALL ACCESS
                  Domestic Dial In:       (800) 351-4892
                  International Dial In:  (334) 323-7224
                  Conference Call ID:     ALPHARMA

Investors can access the call in a "listen only" mode via the Internet at

In addition, for those unable to participate at the time of the call, a rebroadcast will be available following the call from Tuesday, February 26, 2008 at 12:00 PM Eastern Standard Time until Tuesday, March 11, 2008 Eastern Standard Time at midnight. The rebroadcast may be accessed on the Internet at or by telephone using the following information:

                            REBROADCAST ACCESS
                   Domestic Dial In:       (877) 919-4059
                   International Dial In:  (334) 323-7226
                   Participant Code:        83509638

About Alpharma

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 80 countries. Alpharma has a growing branded pharmaceutical franchise in the U.S. pain market with its KADIAN® (morphine sulfate extended-release) Capsules, and the FLECTOR® Patch (diclofenac epolamine topical patch). In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Alpharma press releases are also available at our website.

Contact Information

  • Contact:
    Jack Howarth
    Vice President, Investor Relations
    Email Contact